Literature DB >> 7478119

The pathogenetic significance of C5b-9 in IgA nephropathy.

E Alexopoulos1, A Papaghianni, M Papadimitriou.   

Abstract

Renal biopsies from 20 patients with IgAN were retrospectively studied using monoclonal antibodies against T cells, monocytes/macrophages (MM), HLA-DR-related antigen and the C5b-9 neoantigen. Glomerular C5b-9 deposits were mainly found in the mesangial areas and showed an association with IgA (P < 0.005) and C3 deposits (P < 0.001). Interstitial T cells and MM were highly correlated with the interstitial DR + ve cells (P < 0.001 and P < 0.0005 respectively). Tubular C5b-9 deposition was observed on the tubular basement membranes and related to the numbers of interstitial T cells (P < 0.005), MM (P < 0.005) and DR + ve cells (P < 0.01) as well as to the tubular DR expression (P < 0.025). The severity of tubular atrophy and interstitial fibrosis showed a positive correlation with the interstitial T cells, MM and DR + ve cells, as well as with the intensity of tubular C5b-9 deposition (P < 0.05 and P < 0.05 respectively). Plasma creatinine on presentation was correlated with the numbers of interstitial T cells (P < 0.05), MM (P < 0.01), interstitial DR + ve cells (P < 0.005), and tubular C5b-9 deposits (P < 0.005). No correlation between glomerular T cells, MM, and C5b-9 deposits with plasma creatinine was seen. During follow-up, renal function deteriorated in those patients with the more extensive tubular C5b-9 deposits. In conclusion, glomerular C5b-9 deposition seems to be secondary to the IgA and C3 deposition. In contrast, tubular C5b-9 is related to the numbers of interstitial T cells and MM. Activated interstitial mononuclear cells may lead to the tubular deposition of C5b-9, which eventually might contribute to the development of tubulointerstitial lesions (TIL) and renal function impairment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478119

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  Inflammatory processes in renal fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

2.  Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation.

Authors:  Takayoshi Miura; Shin Goto; Seitaro Iguchi; Hisaki Shimada; Mitsuhiro Ueno; Shin-ichi Nishi; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2010-11-06       Impact factor: 2.801

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 4.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Authors:  Dana V Rizk; Nicolas Maillard; Bruce A Julian; Barbora Knoppova; Todd J Green; Jan Novak; Robert J Wyatt
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 5.  Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.

Authors:  Jacob J E Koopman; Mieke F van Essen; Helmut G Rennke; Aiko P J de Vries; Cees van Kooten
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

6.  Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study.

Authors:  Anna Broder; H Michael Belmont; Shudan Wang; Ming Wu; Luis Chiriboga; Briana Zeck; Beatrice Goilav; Shuwei Wang; Alejandra Londono Jimenez; Chaim Putterman; Daniel Schwartz; James Pullman
Journal:  Lupus Sci Med       Date:  2022-01

7.  Urinary C5b-9 as a Prognostic Marker in IgA Nephropathy.

Authors:  Byung Chul Yu; Jin Hoon Park; Kyung Ho Lee; Young Seung Oh; Soo Jeong Choi; Jin Kuk Kim; Moo Yong Park
Journal:  J Clin Med       Date:  2022-02-03       Impact factor: 4.241

Review 8.  The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?

Authors:  Felix Poppelaars; Bernardo Faria; Wilhelm Schwaeble; Mohamed R Daha
Journal:  J Clin Med       Date:  2021-10-14       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.